Easy NAPLEX Cardiovascular Pharmacology Practice Questions

Concept Explanation

Easy NAPLEX cardiovascular pharmacology focuses on the foundational mechanisms, therapeutic indications, and common side effects of drugs used to treat hypertension, heart failure, and hyperlipidemia. Mastery of these agents requires understanding how medications like ACE inhibitors, beta-blockers, statins, and diuretics interact with physiological processes to maintain hemodynamic stability. For a broader overview of exam preparation, visit our NAPLEX Prep hub.

Pharmacotherapy in this domain often involves balancing efficacy with safety profiles. For instance, clinicians must identify when to initiate therapy based on current clinical guidelines, such as those provided by the American College of Cardiology. Understanding drug classes, such as the difference between dihydropyridine and non-dihydropyridine calcium channel blockers, is essential for passing the NAPLEX pharmacology section.

Solved Examples

1. Question: A 65-year-old patient with a history of diabetes and chronic kidney disease requires a new antihypertensive agent. Which class of medication is preferred for its renal protective properties?
   Solution: ACE inhibitors (e.g., lisinopril) or ARBs (e.g., losartan) are the preferred agents. These drugs reduce intraglomerular pressure, providing renoprotection in patients with diabetic nephropathy.
2. Question: A patient is started on amlodipine and reports new-onset peripheral edema. What is the mechanism of this side effect?
   Solution: Amlodipine is a dihydropyridine calcium channel blocker that causes peripheral vasodilation by inhibiting calcium influx into vascular smooth muscle. This leads to increased hydrostatic pressure in the capillaries, resulting in fluid extravasation into the tissues.
3. Question: Which lipid-lowering agent is associated with a risk of myopathy and rhabdomyolysis, requiring monitoring of creatine kinase levels if symptoms occur?
   Solution: HMG-CoA reductase inhibitors, commonly known as statins (e.g., atorvastatin, rosuvastatin), are well-documented to cause muscle-related adverse effects, ranging from mild myalgia to rare cases of rhabdomyolysis.

Practice Questions

1. Which of the following medications is a contraindication in patients with a history of heart failure with reduced ejection fraction (HFrEF)?
   A) Lisinopril
   B) Carvedilol
   C) Verapamil
   D) Spironolactone
2. A patient on warfarin therapy experiences a sudden increase in their INR after starting a new antibiotic. Which interaction is most likely responsible?
   A) CYP450 induction
   B) CYP450 inhibition
   C) P-glycoprotein efflux
   D) Protein binding displacement
3. Which diuretic class is most likely to cause hyperkalemia as a primary side effect?
   A) Thiazide diuretics
   B) Loop diuretics
   C) Potassium-sparing diuretics
   D) Carbonic anhydrase inhibitors

4. Which beta-blocker is cardioselective and preferred in patients with mild asthma or COPD?
   A) Propranolol
   B) Metoprolol succinate
   C) Carvedilol
   D) Nadolol
5. What is the primary mechanism of action of digoxin in the treatment of heart failure?
   A) Inhibition of the Na+/K+-ATPase pump
   B) Beta-1 receptor antagonism
   C) Direct vasodilation
   D) ACE inhibition
6. A patient presenting with acute coronary syndrome is prescribed dual antiplatelet therapy. Which agents are commonly included?
   A) Aspirin and Clopidogrel
   B) Warfarin and Aspirin
   C) Apixaban and Clopidogrel
   D) Rivaroxaban and Aspirin
7. Which medication is considered a first-line treatment for hypertension in African American patients?
   A) Lisinopril
   B) Losartan
   C) Amlodipine
   D) Propranolol
8. Which statin is considered high-intensity at a dose of 40-80 mg?
   A) Simvastatin
   B) Pravastatin
   C) Atorvastatin
   D) Lovastatin

Answers & Explanations

1. C (Verapamil). Non-dihydropyridine CCBs have negative inotropic effects and should generally be avoided in patients with HFrEF.
2. B (CYP450 inhibition). Many antibiotics, such as clarithromycin or sulfamethoxazole/trimethoprim, inhibit the metabolism of warfarin, leading to increased levels and higher bleeding risk.
3. C (Potassium-sparing diuretics). Agents like spironolactone or triamterene interfere with sodium reabsorption in the collecting tubule, leading to potassium retention.
4. B (Metoprolol succinate). Metoprolol is a beta-1 selective blocker, making it safer for patients with reactive airway disease compared to non-selective agents like propranolol.
5. A (Inhibition of the Na+/K+-ATPase pump). By inhibiting this pump, intracellular sodium increases, which facilitates calcium entry via the Na+/Ca2+ exchanger, increasing myocardial contractility.
6. A (Aspirin and Clopidogrel). Dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor is the standard of care to prevent stent thrombosis.
7. C (Amlodipine). Guidelines recommend calcium channel blockers or thiazide diuretics as initial therapy for hypertension in black patients, as they often have lower renin levels.
8. C (Atorvastatin). Atorvastatin 40-80 mg is categorized as high-intensity statin therapy, capable of lowering LDL-C by ≥50%.

1. Which medication class is linked to a dry, persistent cough?

• ABeta-blockers
• BACE inhibitors
• CCalcium channel blockers
• DThiazide diuretics

Frequently Asked Questions

Why are ACE inhibitors preferred for diabetic patients with hypertension?

ACE inhibitors reduce intraglomerular pressure by dilating the efferent arteriole, which slows the progression of albuminuria and protects kidney function in diabetic patients.

What is the difference between HFrEF and HFpEF?

HFrEF involves a reduced ejection fraction (≤40%) due to systolic dysfunction, while HFpEF involves a preserved ejection fraction (≥50%) characterized by diastolic dysfunction. Treatments vary significantly based on these classifications.

When should you monitor a patient on statin therapy?

Baseline liver function tests and lipid panels are recommended. While routine CK monitoring is not required, clinicians should assess for muscle pain or weakness during follow-up visits.

How do beta-blockers affect heart rate and contractility?

Beta-blockers antagonize beta-1 adrenergic receptors, resulting in a negative chronotropic effect (reduced heart rate) and negative inotropic effect (reduced contractility).

What is the role of the CDC in cardiovascular guidelines?

The CDC provides public health guidance on cardiovascular disease prevention, focusing on population-level strategies for blood pressure and cholesterol management.